Researchers at the University of California, San Francisco have developed a groundbreaking two-step genome editing technique, enabling the creation of full-length humanized mouse models. This advancement,...
Cabaletta Bio, a Philadelphia-based biotechnology company, has announced promising results from its recent clinical trial involving CAR-T therapy for a rare autoimmune disorder. The findings indicate...
